Skip to main content
. 2024 Jan 31;9(3):263–271. doi: 10.1001/jamacardio.2023.5366

Table 3. Hazard Ratios for Coronary Heart Disease Associated With Familial Hypercholesterolemia (FH) Variant Status.

FH variant status Mean (SD) Incidence rate per 1000 person-years (95% UI) Hazard ratio (95% CI)
Baseline LDL-C Time-weighted LDL-Ca Model 1b Model 2c Model 3d
Among participants with baseline detreated LDL-C 130-189 mg/dL (n = 8295)
No FH variant 152.4 (15.8) 133.0 (11.7) 8.7 (8.3-9.2) 1 [Reference] 1 [Reference] 1 [Reference]
FH variant 165.8 (15.7) 181.2 (15.9) 11.5 (4.8-27.7) 2.9 (1.4-6.0) 2.6 (1.2-5.4) 1.3 (0.6-2.9)
Among participants with baseline detreated LDL-C ≥190 mg/dL (n = 1337)
No FH variant 218.5 (31.4) 164.9 (18.2) 12.2 (10.9-13.6) 1 [Reference] 1 [Reference] 1 [Reference]
FH variant 257.6 (66.7) 243.9 (36.7) 14.0 (7.5-26.0) 2.6 (1.4-4.9) 2.4 (1.3-4.4) 1.9 (0.9-3.9)

Abbreviations: LDL-C, low-density lipoprotein cholesterol; UI, uncertainty interval.

a

Time-weighted mean (SD) LDL-C from age 20 years to study baseline was estimated using linear mixed-effects model.

b

Model 1 is adjusted for race, ethnicity, sex, smoking status, body mass index, high-density lipoprotein cholesterol, systolic blood pressure, diabetes, use of lipid-lowering medications, and use of antihypertensive medications and stratified by study cohort.

c

Model 2: model 1 and LDL-C at study baseline.

d

Model 3: model 1 and time-weighted average LDL-C from age 20 years to study baseline.